Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Cullinan Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 106 | 2 | 113 | +9 |
| Shares | 38.0M | 3.48M | 36.9M | +2.33M (+6.7%) |
| Value | $344.0M | $31.5M | $375.6M | +$63.1M (+20.2%) |
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 3,419,842 | $34.8M | 8.33% |
| Affinity Asset Advisors, LLC | 300,000 | $3.06M | 0.61% |
| Two Sigma Investments, LP | 50,342 | $513.0K | 0.00% |
| Two Sigma Advisers, LP | 38,600 | $393.3K | 0.00% |
| Trexquant Investment LP | 34,955 | $356.2K | 0.01% |
| Marshall Wace, LLP | 33,374 | $340.1K | 0.00% |
| Putnam Investments LLC | 22,210 | $226.3K | 0.00% |
| Squarepoint Ops LLC | 20,067 | $204.5K | 0.00% |
| Quest Partners LLC | 17,601 | $179.4K | 0.04% |
| NEOS Investment Management LLC | 15,906 | $162.1K | 0.02% |
| Bailard, Inc. | 10,800 | $110.1K | 0.00% |
| Invesco Ltd. | 10,623 | $108.2K | 0.00% |
| Gsa Capital Partners LLP | 10,246 | $104.0K | 0.01% |
| Vontobel Holding Ltd. | 10,000 | $101.9K | 0.00% |
| Qube Research & Technologies Ltd | 6,846 | $69.8K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 2,852 | $29.1K | 0.01% |
| Russell Investments Group, Ltd. | 2,300 | $23.4K | 0.00% |
| Parallel Advisors, LLC | 1,317 | $13.4K | 0.00% |
| GAMMA Investing LLC | 412 | $6.24K | 0.00% |
| US Bancorp | 504 | $5.14K | 0.00% |
| Lindbrook Capital, LLC | 291 | $2.96K | 0.00% |
| Quadrant Capital Group LLC | 241 | $2.46K | 0.00% |
| Massmutual Trust Co FSB | 36 | $367 | 0.00% |
Sold out (14)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,150,000 | $10.4M |
| Boxer Capital, LLC | 1,074,082 | $9.72M |
| Assenagon Asset Management S.A. | 609,106 | $5.51M |
| Velan Capital Investment Management LP | 75,000 | $678.8K |
| Group One Trading, L.P. | 43,182 | $390.8K |
| AQR Capital Management LLC | 21,774 | $197.1K |
| Federated Hermes, Inc. | 20,000 | $181.0K |
| State of Wisconsin Investment Board | 15,258 | $138.1K |
| SVB Financial Group | 13,516 | $122.3K |
| Allspring Global Investments Holdings, LLC | 7,095 | $64.2K |
| Point72 Asset Management, L.P. | 224 | $2.03K |
| Covestor Ltd | 123 | $1.00K |
| Baker Avenue Asset Management, LP | 48 | $434 |
| Capital Advisors, Ltd. LLC | 37 | $0 |
Not filed for Q4 2023 yet (2)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 3,414,189 | $30.9M |
| Virginia Retirement Systems Et Al | 64,700 | $585.5K |